Overview of the world of EGFR mutant lung cancers

Non-TKI-based treatment options for EGFR-mutant lung cancerПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

2023 World Conference on Lung Cancer Highlights | Dr. Stephen Liu | Oncology Brothers #2023Подробнее

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

EGFR Exon-20 Mutation - Lung Cancer Video LibraryПодробнее

Therapeutic strategies for EGFR-mutated lung cancerПодробнее

Dr Amit Kumar | Real World Landscape of EGFR C797X Mutation as a Resistance MechanismПодробнее

Dr. Pinaki Mahoto - Harboring EGFR mutations: Results from a real-world study in South KoreaПодробнее

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLCПодробнее

EGFR TKIs Excite Treatment Landscape of EGFR-Mutant Lung CancersПодробнее

Genomic Landscape of Lung AdenocarcinomaПодробнее

Molecular Testing for EGFR Mutations: What Pathologists Need to KnowПодробнее

Tumor clonality in EGFR mutation-positive NSCLCПодробнее

Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLCПодробнее

Sylvester Global Oncology - Lung Cancer Review 2017 WebinarПодробнее

Emerging Data in EGFR-Mutant Lung CancerПодробнее

Resistance in EGFR-Mutant Lung CancerПодробнее

Studies on EGFR mutants in NSCLCПодробнее

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and PromisesПодробнее